Bone Marrow Immunophenotypic Analysis Allows the Identification of High Risk of Progression and Immune Condition-Related Monoclonal Gammopathy of Undetermined Significance.

被引：0
|
作者：
Jerez, Andres [1 ]
Ortuno, Francisco [1 ]
del Mar Osma, Maria [1 ]
Espanol, Ignacio [3 ]
Gonzalez, Ana [2 ]
de Arriba, Felipe [1 ]
Roldan, Vanessa [1 ]
Garcia, Vicente [1 ]
机构：
[1] Hosp Morales Meseguer, Murcia, Spain
[2] Hosp Los Arcos, Santiago De La Ribera, Spain
[3] Hosp Rafael Mendez, Lorca, Spain
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1097 / 1097
页数：1
相关论文
共 18 条
  • [11] Magnetic resonance (MR) imaging of the bone marrow to assess the risk of disease progression in patients with monoclonal gammapathy of undetermined significance (MGUS)
    Lecouvet, F
    VandeBerg, B
    Michaux, L
    Labaisse, MA
    Ferrant, A
    Malghem, J
    Maldague, B
    Michaux, JL
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1137 - 1137
  • [12] Percentage of Aberrant Plasma Cells in the Bone Marrow Plasma Cell Compartment by Flow Cytometry: Correlation with Genetic Changes Involved in Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Kwok, B.
    Yung, A.
    Reddy, P.
    Badr, R.
    Dabbas, B.
    Xu, Y.
    LABORATORY INVESTIGATION, 2013, 93 : 339A - 339A
  • [13] Percentage of Aberrant Plasma Cells in the Bone Marrow Plasma Cell Compartment by Flow Cytometry: Correlation with Genetic Changes Involved in Progression of Monoclonal Gammopathy of Undetermined Significance (MGUS)
    Kwok, B.
    Yung, A.
    Reddy, P.
    Badr, R.
    Dabbas, B.
    Xu, Y.
    MODERN PATHOLOGY, 2013, 26 : 339A - 339A
  • [14] Evaluation of Current Clinical Models for Risk of Progression from Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma or Related Malignancies in 2028 Persons Followed in the Czech Republic
    Sandecka, Viera
    Adam, Zdenek
    Spicka, Ivan
    Scudla, Vlastimil
    Gregora, Evzen
    Maisnar, Vladimir
    Brozova, Lucie
    Jarkovsky, Jiri
    Rihova, Lucie
    Mikulasova, Aneta
    Starostka, David
    Walterova, Lenka
    Adamova, Dagmar
    Kessler, Petr
    Brejcha, Martin
    Vonke, Ivan
    Obernauerova, Jarmila
    Valentova, Kamila
    Pour, Ludek
    Minarik, Jiri
    Straub, Jan
    Radocha, Jakub
    Gumulec, Jaromir
    Hajek, Roman
    BLOOD, 2014, 124 (21)
  • [15] New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
    Perez-Persona, Ernesto
    Vidriales, Maria-Belen
    Mateo, Gema
    Garcia-Sanz, Ramon
    Mateos, Maria-Victoria
    de Coca, Alfonso Garcia
    Galende, Josefina
    Martin-Nunez, Guillermo
    Alonso, Jose M.
    de las Heras, Natalia
    Hernandez, Jose M.
    Martin, Alejandro
    Lopez-Berges, Consuelo
    Orfao, Alberto
    San Miguel, Jesus F.
    BLOOD, 2007, 110 (07) : 2586 - 2592
  • [16] Transcriptome-Wide Analysis of Bone Marrow CD19+Cells As Well As Bone Marrow B Cell Clones of Waldenstrom's Macroglobulinemia (WM) Vs. IgM Monoclonal Gammopathy of Undetermined Significance (IgM-MGUS)
    Trojani, Alessandra
    Greco, Antonino
    Tedeschi, Alessandra
    Lodola, Milena
    Di Camillo, Barbara
    Frustaci, Anna Maria
    Morra, Enrica
    BLOOD, 2014, 124 (21)
  • [17] Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells
    Perez-Persona, Ernesto
    Mateo, Gema
    Garcia-Sanz, Ramon
    Mateos, Maria-Victoria
    de las Heras, Natalia
    Garcia de Coca, Alfonso
    Hernandez, Jose M.
    Galende, Josefina
    Martin-Nunez, Guillermo
    Barez, Abelardo
    Alonso, Jose M.
    Martin, Alejandro
    Lopez-Berges, Consuelo
    Orfao, Alberto
    San Miguel, Jesus F.
    Vidriales, Maria-Belen
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (01) : 110 - 114
  • [18] A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenstrom macroglobulinaemia or other lymphoproliferative disorders
    Varettoni, Marzia
    Zibellini, Silvia
    Boveri, Emanuela
    Klersy, Catherine
    Candido, Chiara
    Rattotti, Sara
    Ferretti, Virginia V.
    Defrancesco, Irene
    Mangiacavalli, Silvia
    Nizzoli, Maria E.
    Flospergher, Elena
    Zerbi, Caterina
    Bergamini, Fabio
    Benvenuti, Pietro
    Brociner, Marco
    Merati, Gabriele
    Paulli, Marco
    Arcaini, Luca
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 187 (04) : 441 - 446
12